Site 38 - Northwestern University, Feinberg School of Medicine, Northwestern University is a clinical research site located in Chicago, Illinois, United States 60611.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Site 38 - Northwestern University, Feinberg School of Medicine, Northwestern University has participated in 1 clinical trials.
Therapeutic areas: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer.
Sponsors: Carrick Therapeutics Limited.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Site 38 - Northwestern University, Feinberg School of Medicine, Northwestern University has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Site 38 - Northwestern University, Feinberg School of Medicine, Northwestern University has 1 clinical trials on record. Their work covers Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer.
Site 38 - Northwestern University, Feinberg School of Medicine, Northwestern University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.